Hi-Tech Pharmacal Co Inc (NASDAQ:HITK)

43.49
Data as of Apr 16
 0.00 / 0.00%
Today’s Change
29.24
Today|||52-Week Range
44.33
+0.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$602.3M

Company Description

Hi-Tech Pharmacal Co., Inc. is a pharmaceutical company which manufactures and markets prescription, over-the-counter and nutritional products. The company produces products for various disease states, including glaucoma, asthma, bronchial disorders, dermatological disorders, allergies, pain, stomach, oral care and other conditions. It operates through three reportable segments: Generic Pharmaceuticals, OTC Branded Pharmaceuticals and Prescription Brands. The Generic Pharmaceuticals segment products primarily prescription items and include oral solutions and suspensions, topical creams and ointments as well as nasal sprays. It also specializes in the manufacture of products in its sterile facility capable of producing liquid ophthalmic, otic and inhalation products. The generic product category includes a small amount of contract manufacturing sales for both the prescription and OTC markets. OTC Branded Pharmaceuticals operates Health Care Products Division, which markets a line of OTC branded products primarily for people with diabetes, including Diabetic Tussin, DiabetiDerm, Multi-betic, Mag-Ox, Choice DM and DiabetiSweet. It also sells the Zostrix brand of capsaicin products for pain management of conditions including arthritis and foot pain. The Prescription Brands segment operates ECR Pharmaceuticals subsidiary, which engaged in the marketing and distribution of branded prescription pharmaceuticals. ECR's products treat various disease states, including tension headache, pain, cough/cold and allergies, contact dermatitis, wound care, sleep disorders and swimmer's ear. Hi-Tech Pharmacal was founded in April 1982 and is headquartered in Amityville, NY.

Contact Information

Hi-Tech Pharmacal Co., Inc.
369 Bayview Avenue
Amityville New York 11701
P:(631) 789-8228
Investor Relations:

Employees

Shareholders

Mutual fund holders40.69%
Individual stakeholders26.42%
Other institutional20.88%

Top Executives

David S. SeltzerChairman, President, CEO, Secretary & Treasurer
Eyal MaresVice President-Operations
William J. PetersChief Financial Officer, VP & Head-Media Relations
Polireddy DondetiVice President-Research & Development
James P. TracyVice President-Information Technology

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.